Immunocore Holdings plc
IMCR81
$28.56arrow_drop_down4.74%-$1.42
High Growth
IMCR81
$28.56
arrow_drop_down4.74%| Key Stats | |
|---|---|
| Open | $30.20 |
| Prev. Close | $30.03 |
| EPS | -0.95 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 26.63 | 30.55 |
| 52 Week Range | 26.63 | 76.98 |
| Ratios | |
|---|---|
| EPS | -0.95 |
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.97% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
IMCR-
US Healthcare Sector-
US Market-
warning
IMCR / Market
IMCR lose to the US Market which returned 1.32% over the last twenty four hours.warning
IMCR / Healthcare Sector
IMCR lose to the US Healthcare sector which returned 1.94% over the last twenty four hours.Immunocore Holdings plc (IMCR) Statistics
Keep an eye on Immunocore Holdings plc
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is the EPS of Immunocore Holdings plc (IMCR) stock?
The Earnings Per Share (EPS) for Immunocore Holdings plc (IMCR), calculated on a diluted basis, is -$0.95. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Immunocore Holdings plc (IMCR) stock?
The operating margin for Immunocore Holdings plc (IMCR) is -10.6%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Immunocore Holdings plc (IMCR) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Immunocore Holdings plc (IMCR) is -$64.89M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Immunocore Holdings plc (IMCR) have?
Immunocore Holdings plc (IMCR) has a total debt of $481.06M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$56.7M.
help
How has Immunocore Holdings plc (IMCR) stock's performance compared to its sector and the market over the past year?
Over the past year, Immunocore Holdings plc (IMCR) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 23.16%, Immunocore Holdings plc has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 46.21%, it has fallen short of the market average. This comparison highlights Immunocore Holdings plc's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Immunocore Holdings plc (IMCR) stock?
The PE ratio for Immunocore Holdings plc (IMCR) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.